Scholars Central

Mini reviewPublished 28 Feb 2023

Molecular Mechanism of Ferula Asafoetida for the Treatment of Asthma: Network Pharmacology and Molecular Docking Approach

Authors: Md. Rafat Tahsin

Department of Public Health, Daffodil International University, Dhaka, Bangladesh

Journal of Cellular and Molecular Pharmacology

Volume 7 · Issue 1 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Asthma is a significant health-care burden that has great impact on the quality of life of patients and their families. The limited amount of previously reported data and complicated pathophysiology of asthma make it a difficult to treat and significant economic burden on public healthcare systems. Ferula asafoetida is an herbaceous, monoecious, perennial plant of the Umbelliferae family. In Asia, F. asafoetida is used to treat a range of diseases and disorders, including asthma. Several in vitro studies demonstrated the therapeutic efficacy of F. asafoetida against asthma. Nevertheless, the precise molecular mechanism is yet to be discovered. In the framework of current study, network pharmacology approach was used to identify the bioactive compounds of F. asafoetida in order to better understand its molecular mechanism for the treatment of asthma. In present work, we explored a compoundtarget- pathway network and discovered that assafoetidin, cynaroside, farnesiferol-B, farnesiferol-C, galbanicacid, and luteolin significantly influenced the development of asthma by targeting MAPK3, AKT1 and TNF genes. Later, docking analysis revealed that active constituents of F. asafoetida bind stably with three target proteins and function as asthma repressor by regulating the expression of MAPK3, AKT1 and TNF genes. Thus, integration of network pharmacology with molecular docking revealed that F. asafoetida prevent asthma by modulating asthmarelated signaling pathways. This study lays the basis for establishing the efficacy of multi-component, multi-target compound formulae, as well as investigating new therapeutic targets for asthma.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cellular and Molecular Pharmacology
  • SubjectPharmaceutical Sciences
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Md. Rafat Tahsin”